According to Immutep's latest financial reports the company has $90.33 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-06-30 | $90.33 M | 39.56% |
2022-06-30 | $64.72 M | 17.58% |
2021-06-30 | $55.05 M | 140.59% |
2020-06-30 | $22.88 M | 33.6% |
2019-06-30 | $17.12 M | -30.94% |
2018-06-30 | $24.8 M | 21.63% |
2017-06-30 | $20.39 M | -22.71% |
2016-06-30 | $26.38 M | 39.26% |
2015-06-30 | $18.94 M | -10.96% |
2014-06-30 | $21.27 M | -20.32% |
2013-06-30 | $26.7 M | -29.82% |
2012-06-30 | $38.04 M | -35.42% |
2011-06-30 | $58.91 M | 342.09% |
2010-06-30 | $13.32 M | 812% |
2009-06-30 | $1.46 M | -42.08% |
2008-06-30 | $2.52 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Illumina ILMN | $5.74 B | 6,259.39% | ๐บ๐ธ USA |
FibroGen FGEN | -$0.17 B | -279.55% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | $0.47 M | -99.47% | ๐บ๐ธ USA |